Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: services he lit cfm
Measurement Strategies With a deep understanding of the regulatory environment and reimbursement issues pertaining to clinical outcome assessments (COAs), we work with you to develop and support optimal measurement strategies for your products in …
… particularly as related to public health topics, and he has extensive experience in all aspects of retrospective … disorders, cardiovascular health, and infectious disease. He has also conducted research to characterize treatment … of Surgical Oncology, Journal of Pharmaceutical Health Services Research, Current Medical Research and Opinion, BMC …
Observational Studies Analyzing real-world, observational data requires specialized statistical skills. Our biostatisticians work closely with RTI-HS outcomes researchers to design and analyze data from a wide range of study types, including surveys, …
Multi-Criteria Decision Analysis Most drug development and commercialization choices are complex. When you have multiple factors influencing a decision and you have to consider tradeoffs, you need a tool that can help you compare, prioritize and select …
… and disease management tools. Our instrument-development services apply to all modes of administration (e.g., paper, …
Benefit-Risk Preferences Benefit-risk preference studies are a specific application of stated-preference methods and are used to determine how your patients and other decision-makers perceive the benefits of your treatment features and their tolerance for …
… Shaun Abeysinghe, PhD, is a Senior Director at RTI-HS. He has over 15 years of experience as a biostatistician … analyses, and parametric and multivariate modeling. He has led and won proposals for a variety of different …
… RTI-HS. Mr. Morrison is focused on promoting the clinical services of RTI-HS and designing programs to meet the needs of emerging biotech and pharmaceutical companies. He has 20 years of successful business development experience … including experience specific to preclinical pathology services, early clinical development, phase 2-4 development, …
Global Value Dossiers and Other Value Communication Materials Your messages need to be flexible, tailored to each of your audiences, and clearly articulated. Let us help develop your global value dossiers (GVDs) and other high-impact communication tools …
Regulatory Guidance and Support We can support you throughout your regulatory negotiations. Our team has negotiated with the FDA’s Clinical Outcome Assessments (COA) team and a wide variety of reviewing divisions on numerous occasions to select and …